Inclusion Criteria:  Patients undergoing unilateral cemented hip endoprosthesis for femoral neck fracture Patients aged 50-90 years old Patients with a BMI >18.5 and <35 Patients able to provide informed consent and follow all the study procedures as indicated by the protocol Informed Consent as documented by signature  Exclusion Criteria:  Contraindications to steroids Revision endoprosthesis Active steroid or immunosuppressive therapy in the last 30 days before the operation Pregnant or breast-feeding women Presence of other clinically significant concomitant disease states (ASA IV) Uncontrolled diabetes mellitus Contraindications to NSAIDs Chronic systemic diseases as immunodeficiency, autoimmune disease (Systemic Lupus Erythematosus, SLE), gout, rheumatic arthritis Known or suspected non-compliance, drug or alcohol abuse Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant. Participation in another study with investigational drug within the 30 days preceding and during the present study Previous enrolment into the current study Enrolment of the investigator, his/her family members, employees and other dependent persons.